In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
Crossref DOI link: https://doi.org/10.1038/s41598-022-08559-5
Published Online: 2022-03-18
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Touret, Franck
Baronti, Cécile
Bouzidi, Hawa Sophia
de Lamballerie, Xavier
Text and Data Mining valid from 2022-03-18
Version of Record valid from 2022-03-18
Article History
Received: 2 January 2022
Accepted: 2 March 2022
First Online: 18 March 2022
Competing interests
: The authors declare no competing interests.